ArticleMayo Clinic proceedings2022

Incidence and Risk Factors for Acute Kidney Injury After Chimeric Antigen Receptor T-Cell Therapy.

Naba Farooqui et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.